Author Archive
Michael Babich, the Arizona-based drugmaker's former chief executive officer, and others were charged with participating in a conspiracy in which bribes were disguised as marketing event and speaker fees. The case is the latest involving Subsys, a
Although legal experts think J&J faces an uphill battle, both they and investors believe the Texas jury's penalty, the largest product liability verdict so far this year, is unlikely to stand. In the two-month trial, five
Prime Minister Shinzo Abe's economic advisers, hoping to curb Japan's ballooning healthcare costs, proposed on Wednesday reforms to the way drug prices are set, a step opposed by foreign and domestic drug makers who say the
By Ben Hirschler LONDON (Reuters) - These days the average researcher at Philips is more likely to be a software developer than an product engineer, reflecting a transformation at the former Dutch conglomerate that its chief
By Makini Brice PORT-AU-PRINCE (Reuters) - A former Haitian coup leader wanted by the U.S. Drug Enforcement Administration for alleged cocaine trafficking and money laundering has won election to Haiti's Senate, according to preliminary results released by
A DNA analysis of 2,000-year-old teeth unearthed from an Italian graveyard has offered hard evidence that malaria existed during the Roman Empire, researchers said Monday. The findings are based on mitochondrial DNA -- genetic material inherited
A U.S. Justice Department attorney told a federal judge on Monday that health insurer Aetna Inc's planned acquisition of Humana Inc would break antitrust law by reducing competition in Medicare Advantage and Obamacare exchange businesses, kicking
OAKLAND, Calif. (AP) — David West has undergone four surgeries in his long NBA career: left knee, right elbow and right foot twice to fix a couple of toes.
OAKLAND, Calif. (AP) — David West has undergone four surgeries in his long NBA career: left knee, right elbow and right foot twice to fix a couple of toes.
An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young adults treated with modified immune cells in a mid-stage trial, the company said